Comparative Pharmacology
Head-to-head clinical analysis: AMMONIUM CHLORIDE 2 14 versus AMMONIUM CHLORIDE IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMMONIUM CHLORIDE 2 14 versus AMMONIUM CHLORIDE IN PLASTIC CONTAINER.
AMMONIUM CHLORIDE 2.14% vs AMMONIUM CHLORIDE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ammonium chloride is an acidifying agent. It dissociates into ammonium and chloride ions. The ammonium ion is metabolized in the liver to urea and hydrogen ions, leading to metabolic acidosis. This reduces blood pH and increases renal excretion of alkaline urine.
Ammonium chloride is an acidifying agent that provides chloride ions and ammonium ions. The ammonium ion is converted to urea in the liver, releasing hydrogen ions, which leads to metabolic acidosis. It also directly stimulates the respiratory center and promotes diuresis by increasing the osmotic load.
For metabolic alkalosis: 1.5 to 3 g (approximately 280 to 560 mEq) intravenously over 4 to 6 hours; adjust based on serum chloride and pH.
For metabolic alkalosis: 1-2 g intravenously every 6-12 hours as needed; maximum 6 g/day. For hypochloremic states: 1-2 g orally or intravenously 2-3 times daily.
None Documented
None Documented
4-6 hours; prolonged in renal impairment (up to 12-15 hours).
Terminal elimination half-life is approximately 2-4 hours in adults with normal hepatic and renal function. This reflects the rapid conversion of ammonium to urea in the liver and subsequent renal clearance. Half-life may be prolonged in hepatic or renal impairment.
Renal: >99% as ammonium ion and chloride; minimal biliary/fecal elimination.
Renal: >99% as ammonium and chloride ions. The kidney converts ammonia to urea, which is excreted in urine. Fecal and biliary elimination are negligible.
Category C
Category C
Expectorant/Systemic Acidifier
Expectorant/Systemic Acidifier